Is Apple the Teflon Tech Stock? And the Latest Moves in the Weight Loss Drug Space 6/26/23
CNBC's "Fast Money"
00:00
The Cost of BCA Drugs
I'm just wondering if you're going to think about the sort of ancillary impacts, I mean, if all these people are losing weight and reducing their risk for other sort of, you know, heart disease, high blood pressure, et cetera. Yeah, it's a great question. You know, there's a different type of strategy for this. In general, though, I would say in the near term, the cost will be driven by the drug. The economic benefits will be driven in the outer years but for sure, though, it's not just about weight.
Play episode from 32:23
Transcript
